Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin
Authors
Keywords
-
Journal
NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 21, Issue 4, Pages 383-388
Publisher
Springer Nature
Online
2014-03-24
DOI
10.1038/nsmb.2797
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma
- (2013) Elizabeth E. Gerber et al. NATURE
- Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor
- (2012) Masamichi Nagae et al. JOURNAL OF CELL BIOLOGY
- Structure-Guided Design of a High-Affinity Platelet Integrin IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS
- (2012) J. Zhu et al. Science Translational Medicine
- Integrins as therapeutic targets
- (2012) Simon L. Goodman et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Regulation of Integrin αIIbβ3 Ligand Binding and Signaling by the Metal Ion Binding Sites in the β I Domain
- (2011) Joel Raborn et al. BIOCHEMISTRY
- Identification of Integrin β Subunit Mutations That Alter Affinity for Extracellular Matrix Ligand
- (2011) Timmy Kendall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Integrins as therapeutic targets: lessons and opportunities
- (2010) Dermot Cox et al. NATURE REVIEWS DRUG DISCOVERY
- A Monoclonal Antibody Against V 3 Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs
- (2010) L. A. Maile et al. Science Translational Medicine
- Structure of an integrin with an αI domain, complement receptor type 4
- (2009) Can Xie et al. EMBO JOURNAL
- AnN-Glycosylation Site on theβ-Propeller Domain of the Integrin α5 Subunit Plays Key Roles in Both Its Function and Site-specific Modification byβ1,4-N-Acetylglucosaminyltransferase III
- (2009) Yuya Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal structure of the complete integrin αVβ3 ectodomain plus an α/β transmembrane fragment
- (2009) Jian-Ping Xiong et al. JOURNAL OF CELL BIOLOGY
- Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcγRIIa and the integrin β3 cytoplasmic domain
- (2009) Cunji Gao et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management
- (2009) R. H. ASTER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
- (2009) Gian Carlo Alghisi et al. PLoS One
- Clustering of 5 1 integrins determines adhesion strength whereas v 3 and talin enable mechanotransduction
- (2009) P. Roca-Cusachs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanically Activated Integrin Switch Controls 5 1 Function
- (2009) J. C. Friedland et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More